Chernova NI¹ and Zadorozhnaya IS²*

¹Department of Healthcare, Moscow Research and Practical Center for Dermatovenerology and Cosmetology, Moscow, Russian Federation
²Moscow State Medical and Dental University Named After A.I. Evdokimova, Moscow, Russian Federation

*Corresponding Author: Zadorozhnaya IS, Moscow State Medical and Dental University Named After A.I. Evdokimova, Moscow, Russian Federation.

Received: March 02, 2021; Published: May 21, 2021

Citation: Chernova NI and Zadorozhnaya IS. “The Importance of Using Topical Glucocorticosteroid Drugs in the Treatment of Vulvovaginal-gingival Syndrome. A Clinical Case in a Young Patient". Acta Scientific Microbiology 5.6 (2021): 125-128.

Abstract

  The presented clinical case demonstrates the development of complications of the vulvovaginal-gingival syndrome (VVGS) in a 22-year-old patient. The pathognomonic clinical symptoms of the disease from erosions of the oral mucosa, vulva and vagina to the loss of the labia minora, stenosis of the vaginal opening, scarring and strictures on the background of systemic therapy are displayed. Establishment of remission with the use of ultrapotent topical glucocorticoid drugs and personal hygiene products.

Keywords: Vulvovaginal-gingival Syndrome; Vulvovaginal Lichen Planus

Bibliography

1. Lewis F M., et al. "Vulval involvement in lichen planus: a study of 37 women”. British Journal of Dermatology 1 (1996): 89-91.
2. Eisen Drore. "The clinical features, malignant potential, and systemic associations of oral lichen planus: a study of 723 patients”. Journal of the American Academy of Dermatology 2 (2002): 207-214.
3. Day Tania Julie Weigner and James Scurry. "Classic and hypertrophic vulvar lichen planus”. Journal of Lower Genital Tract Disease4 (2018): 387.
4. Yang Min., et al. "Clinical analysis of 11 cases of vulvovaginal-gingival syndrome”. Chinese Journal of Dermatology 5 (2017): 351-354.
5. Cooper Susan M and Fenella Wojnarowska. "Influence of treatment of erosive lichen planus of the vulva on its prognosis”. Archives of Dermatology3 (2006): 289-294.
6. Eisen D., et al. "Number V Oral lichen planus: clinical features and management”. Oral Diseases6 (2005): 338-349.
7. Petruzzi Massimo., et al. "Topical retinoids in oral lichen planus treatment: an overview”. Dermatology1 (2013): 61-67.
8. Bradford Jennifer and Gayle Fischer. "Management of vulvovaginal lichen planus: a new approach”. Journal of Lower Genital Tract Disease1 (2013): 28-32.
9. Panagiotopoulou N., et al. "Vulvovaginal-gingival syndrome”. Journal of Obstetrics and Gynaecology 3 (2010): 226-230.
10. Setterfield Jane F., et al. "The vulvovaginal gingival syndrome: a severe subgroup of lichen planus with characteristic clinical features and a novel association with the class II HLA DQB1∗ 0201 allele”. Journal of the American Academy of Dermatology 1 (2006): 98-113.

Copyright: © 2021 Chernova NI and Zadorozhnaya IS. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.